Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Boguniewicz

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Allergy and Clinical Immunology|August 3, 2023
The role of Janus kinase signaling in the pathology of atopic dermatitisEmma Guttman-Yassky, Alan D Irvine, Patrick M Brunner, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2010
Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controlsLynda Schneider, Adriana Weinberg, Mark Boguniewicz, et al.
Journal of the American Academy of Dermatology|September 25, 2004
A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitisSteven Kempers, Mark Boguniewicz, Eric Carter, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2003
Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesionsMasao Toda, Donald Y M Leung, Sophie Molet, et al.
The Journal of Pediatrics|August 20, 2013
Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United StatesJosé M Saavedra, Mark Boguniewicz, Sarah Chamlin, et al.
Experimental Dermatology|October 18, 2018
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibitionEmma Guttman-Yassky, Jon M Hanifin, Mark Boguniewicz, et al.
The Journal of Dermatological Treatment|June 28, 2022
Abrocitinib monotherapy in Investigator's Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of lifeAndrew Blauvelt, Mark Boguniewicz, Patrick M Brunner, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2010
Vaccinia virus-specific molecular signature in atopic dermatitis skinDmitry N Grigoryev, Michael D Howell, Tonya N Watkins, et al.
The Journal of Allergy and Clinical Immunology|April 25, 2006
Cathelicidin deficiency predisposes to eczema herpeticumMichael D Howell, Andreas Wollenberg, Richard L Gallo, et al.
Dermatology and Therapy|October 23, 2018
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their FamiliesEric L Simpson, Amy S Paller, Mark Boguniewicz, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Allergy and Clinical Immunology|August 3, 2023
The role of Janus kinase signaling in the pathology of atopic dermatitisEmma Guttman-Yassky, Alan D Irvine, Patrick M Brunner, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2010
Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controlsLynda Schneider, Adriana Weinberg, Mark Boguniewicz, et al.
Journal of the American Academy of Dermatology|September 25, 2004
A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitisSteven Kempers, Mark Boguniewicz, Eric Carter, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2003
Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesionsMasao Toda, Donald Y M Leung, Sophie Molet, et al.
The Journal of Pediatrics|August 20, 2013
Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United StatesJosé M Saavedra, Mark Boguniewicz, Sarah Chamlin, et al.
Experimental Dermatology|October 18, 2018
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibitionEmma Guttman-Yassky, Jon M Hanifin, Mark Boguniewicz, et al.
The Journal of Dermatological Treatment|June 28, 2022
Abrocitinib monotherapy in Investigator's Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of lifeAndrew Blauvelt, Mark Boguniewicz, Patrick M Brunner, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2010
Vaccinia virus-specific molecular signature in atopic dermatitis skinDmitry N Grigoryev, Michael D Howell, Tonya N Watkins, et al.
The Journal of Allergy and Clinical Immunology|April 25, 2006
Cathelicidin deficiency predisposes to eczema herpeticumMichael D Howell, Andreas Wollenberg, Richard L Gallo, et al.
Dermatology and Therapy|October 23, 2018
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their FamiliesEric L Simpson, Amy S Paller, Mark Boguniewicz, et al.
Pageof 16